Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009

The pathology of rheumatoid arthritis includes synoviocyte proliferation and inflammatory mediator expression, which may result from dysregulated epigenetic control by histone deacetylase (HDAC). Thus, HDAC inhibitors may be useful for treating inflammatory disease. This was a preclinical study of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, I-N, Liou, J-P, Lee, H-Y, Lai, M-J, Li, Y-H, Yang, C-R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424110/
https://www.ncbi.nlm.nih.gov/pubmed/24722291
http://dx.doi.org/10.1038/cddis.2014.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424110/
https://www.ncbi.nlm.nih.gov/pubmed/24722291
http://dx.doi.org/10.1038/cddis.2014.133

Ejemplares similares